The U.S. Agency for International Development (USAID) is pleased to present its new Global Health Research and Development Strategy 2023-2028. USAID submits this strategy pursuant to Section 7019(e) of Division K of Public Law 117-103, the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, which incorporates by reference the requirements of the Joint Explanatory Statement that provides:
“The USAID Administrator shall also develop a new multi-year strategy on global health research and development, which shall be submitted to the Committees on Appropriations and posted on the USAID website not later than 180 days after enactment of the Act. Such strategy should include:
- how USAID will work across programs to implement a comprehensive research and development approach;
- plans to collect and use input from the Global Health Bureau, consultations with nonprofit and other private sector partners, and the heads of other relevant Federal agencies, including CDC, the National Institutes of Health, and the Biomedical Advanced Research and Development Authority;
- plans to coordinate with such stakeholders in support of innovative global health product development; and
- specific investment and target goals for research and product development across disease areas.”
This strategy describes USAID’s renewed commitment to research and development (R&D) and use of new, innovative health products and technologies; the implementation and scale-up of real world, evidence-based research and learning to improve health outcomes globally; and the strengthening of both local health research and development capacity and global research and development partnerships.
The United States government has long recognized how scientific and technological innovation, data, and evidence are central to the development and implementation of sound policies and the delivery of equitable programs. Investments in global health protect Americans at home and abroad, save lives, strengthen fragile states, and promote social and economic progress.
USAID plays a critical role in investing in research and development (R&D) that has led to life-saving breakthroughs in prevention, diagnosis, and treatment of global diseases, and to the uptake at scale of critical health and development interventions. Harnessing the power of research and learning has resulted in more efficient and effective programs and advancements in efforts to prevent maternal and child deaths, control the HIV/AIDS epidemic, combat infectious diseases and emerging threats, and strengthen health systems.